ChemGenex completes Omapro rolling NDA

ChemGenex Pharmaceuticals Ltd. (ASX:CXS) completed submission of a rolling NDA to FDA for Omapro omacetaxine mepesuccinate (formerly Ceflatonin) to treat Gleevec-resistant chronic myelogenous leukemia...